DMD and Duchenne muscular dystrophy: Elevidys micro-dystrophin gene therapy has recently been approved by FDA for the treatment of DMD, but micro-dystrophin and mini-dystrophin use highly truncated forms of dystrophin, which may prevent them from offering full protection [9–11].